EUVIMEDObjevte EUVIMED
EditorialKommentar

Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight

Yusuf Yilmaz iD

Alimentary Pharmacology & Therapeutics · 2023

DOI: 10.1111/apt.17460 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, 2023. Written by Yusuf Yilmaz. Institution: Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease. Cited 2 times so far (Crossref); 10 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Ajmera et al papers. To view these articles, visit https://doi.org/10.1111/apt.17452 and https://doi.org/10.1111/apt.17478

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansOverweightObesityFibrosis

Authors and institutions

  • Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
  • Institute of Gastroenterology, Marmara University, İstanbul, Turkey.

ORCID profiles: Yusuf Yilmaz

Cite

APA

Yilmaz, Y. (2023). Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17460

Vancouver

Yilmaz Y. Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17460

BibTeX
@article{Yilmaz2023,
  author = {Yilmaz, Yusuf},
  title = {Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1111/apt.17460}
}
Start for free →